Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2002 11
2003 13
2004 25
2005 32
2006 35
2007 31
2008 35
2009 44
2010 58
2011 54
2012 57
2013 58
2014 96
2015 126
2016 117
2017 109
2018 122
2019 149
2020 183
2021 203
2022 244
2023 282
2024 291
2025 137

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,250 results

Results by year

Filters applied: . Clear all
Page 1
Advances in immunotherapy for triple-negative breast cancer.
Liu Y, Hu Y, Xue J, Li J, Yi J, Bu J, Zhang Z, Qiu P, Gu X. Liu Y, et al. Among authors: yi j. Mol Cancer. 2023 Sep 2;22(1):145. doi: 10.1186/s12943-023-01850-7. Mol Cancer. 2023. PMID: 37660039 Free PMC article. Review.
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment.
Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W. Liu Y, et al. Among authors: jiang y. Biochim Biophys Acta Rev Cancer. 2023 May;1878(3):188890. doi: 10.1016/j.bbcan.2023.188890. Epub 2023 Mar 29. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37001616 Review.
Structures of the entire human opioid receptor family.
Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, Jain MK, Liu W, Melcher K, Jiang Y, Roth BL, Xu HE. Wang Y, et al. Among authors: jiang y. Cell. 2023 Jan 19;186(2):413-427.e17. doi: 10.1016/j.cell.2022.12.026. Epub 2023 Jan 12. Cell. 2023. PMID: 36638794 Free article.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Xu J, Kato K, Raymond E, Hubner RA, Shu Y, Pan Y, Park SR, Ping L, Jiang Y, Zhang J, Wu X, Yao Y, Shen L, Kojima T, Gotovkin E, Ishihara R, Wyrwicz L, Van Cutsem E, Jimenez-Fonseca P, Lin CY, Wang L, Shi J, Li L, Yoon HH. Xu J, et al. Among authors: jiang y. Lancet Oncol. 2023 May;24(5):483-495. doi: 10.1016/S1470-2045(23)00108-0. Epub 2023 Apr 17. Lancet Oncol. 2023. PMID: 37080222 Clinical Trial.
Structures of the glucocorticoid-bound adhesion receptor GPR97-Go complex.
Ping YQ, Mao C, Xiao P, Zhao RJ, Jiang Y, Yang Z, An WT, Shen DD, Yang F, Zhang H, Qu C, Shen Q, Tian C, Li ZJ, Li S, Wang GY, Tao X, Wen X, Zhong YN, Yang J, Yi F, Yu X, Xu HE, Zhang Y, Sun JP. Ping YQ, et al. Among authors: jiang y. Nature. 2021 Jan;589(7843):620-626. doi: 10.1038/s41586-020-03083-w. Epub 2021 Jan 6. Nature. 2021. PMID: 33408414
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.
Zhu X, Hu M, Huang X, Li L, Lin X, Shao X, Li J, Du X, Zhang X, Sun R, Tong T, Ma Y, Ning L, Jiang Y, Zhang Y, Shao Y, Wang Z, Zhou Y, Ding J, Zhao Y, Xuan B, Zhang H, Zhang Y, Hong J, Fang JY, Xiao X, Shen B, He S, Chen H. Zhu X, et al. Among authors: jiang y. Cell Metab. 2025 Apr 1;37(4):806-823.e6. doi: 10.1016/j.cmet.2024.12.013. Epub 2025 Feb 4. Cell Metab. 2025. PMID: 39909032
2,250 results